Cargando…
Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Author(s). Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318407/ https://www.ncbi.nlm.nih.gov/pubmed/34341781 http://dx.doi.org/10.1016/S2666-5247(21)00189-0 |
| _version_ | 1783730236612935680 |
|---|---|
| author | Destras, Grégory Assaad, Souad Bal, Antonin Bouscambert-Duchamp, Maude Avrillon, Virginie Simon, Bruno Valette, Martine Blay, Jean-Yves Lina, Bruno Frobert, Emilie Josset, Laurence |
| author_facet | Destras, Grégory Assaad, Souad Bal, Antonin Bouscambert-Duchamp, Maude Avrillon, Virginie Simon, Bruno Valette, Martine Blay, Jean-Yves Lina, Bruno Frobert, Emilie Josset, Laurence |
| author_sort | Destras, Grégory |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8318407 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | The Author(s). Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83184072021-07-29 Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19 Destras, Grégory Assaad, Souad Bal, Antonin Bouscambert-Duchamp, Maude Avrillon, Virginie Simon, Bruno Valette, Martine Blay, Jean-Yves Lina, Bruno Frobert, Emilie Josset, Laurence Lancet Microbe Correspondence The Author(s). Published by Elsevier Ltd. 2021-09 2021-07-28 /pmc/articles/PMC8318407/ /pubmed/34341781 http://dx.doi.org/10.1016/S2666-5247(21)00189-0 Text en © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Destras, Grégory Assaad, Souad Bal, Antonin Bouscambert-Duchamp, Maude Avrillon, Virginie Simon, Bruno Valette, Martine Blay, Jean-Yves Lina, Bruno Frobert, Emilie Josset, Laurence Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19 |
| title | Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19 |
| title_full | Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19 |
| title_fullStr | Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19 |
| title_full_unstemmed | Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19 |
| title_short | Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19 |
| title_sort | bamlanivimab as monotherapy in two immunocompromised patients with covid-19 |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318407/ https://www.ncbi.nlm.nih.gov/pubmed/34341781 http://dx.doi.org/10.1016/S2666-5247(21)00189-0 |
| work_keys_str_mv | AT destrasgregory bamlanivimabasmonotherapyintwoimmunocompromisedpatientswithcovid19 AT assaadsouad bamlanivimabasmonotherapyintwoimmunocompromisedpatientswithcovid19 AT balantonin bamlanivimabasmonotherapyintwoimmunocompromisedpatientswithcovid19 AT bouscambertduchampmaude bamlanivimabasmonotherapyintwoimmunocompromisedpatientswithcovid19 AT avrillonvirginie bamlanivimabasmonotherapyintwoimmunocompromisedpatientswithcovid19 AT simonbruno bamlanivimabasmonotherapyintwoimmunocompromisedpatientswithcovid19 AT valettemartine bamlanivimabasmonotherapyintwoimmunocompromisedpatientswithcovid19 AT blayjeanyves bamlanivimabasmonotherapyintwoimmunocompromisedpatientswithcovid19 AT linabruno bamlanivimabasmonotherapyintwoimmunocompromisedpatientswithcovid19 AT frobertemilie bamlanivimabasmonotherapyintwoimmunocompromisedpatientswithcovid19 AT jossetlaurence bamlanivimabasmonotherapyintwoimmunocompromisedpatientswithcovid19 |